Liminatus Pharma, Inc. Class A Common Stock (NASDAQ: LIMN) last traded at $3.76, up 1.90% on the session. The quote above updates while this page is open; the figures below are drawn from Liminatus Pharma, Inc. Class A Common Stock’s own filings and are restated only when a new one is published.
Liminatus Pharma, Inc. Class A Common Stock trades on NASDAQ under the ticker LIMN. Its market capitalisation is $252.52 million.
Valuation measures for Liminatus Pharma, Inc. Class A Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $252.52M |
|---|---|
| Price / book | 840.03 |
| Beta | 0.22 |
Trailing-twelve-month figures tagged in Liminatus Pharma, Inc. Class A Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$12.52M |
|---|---|
| Return on equity |
|---|
| -4165.92% |
Range and volume for LIMN over the past 52 weeks.
| 52-week high | $141.50 |
|---|---|
| 52-week low | $3.29 |
| Volume | 16.9K |
| Average volume | 446.6K |
| Previous close | $3.69 |
Invest a chosen dollar amount in Liminatus Pharma, Inc. Class A Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell LIMN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.